Pharma Press Releases By Categories

GlaxoSmithKline has won U.S. approval for a new and improved shingles vaccine, the second of three key products for which the British drugmaker expects approval this year. It also secured a recommendation from UK cost authorities for a $700,000 gene therapy for so-called “bubble boy” disease -- a step forward…
Seattle Genetics, Inc. and Astellas Pharma Inc. announced dosing of the first patient in EV-201, a registrational phase 2 clinical trial of enfortumab vedotin for patients with locally advanced or metastatic urothelial cancer who have been previously treated with checkpoint inhibitor (CPI) therapy. The EV-201 study will assess the antitumor…
BrainStorm Cell Therapeutics Inc announced that the first patients have been enrolled in the Phase 3 clinical trial of NurOwn® for the treatment of ALS at the Massachusetts General Hospital and UC Irvine Medical Center in California. The trial is expected to enroll approximately 200 patients and will be conducted…
Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing announced the launch of its Accel-Amplicon™ Custom NGS Panels. These new panels offer a targeted DNA sequencing product that enables clinical researchers to rapidly design highly focused panels to discover, validate and screen disease genes and their…
Exelixis, Inc. announced that its partner Daiichi Sankyo Company, Limited (“Daiichi Sankyo”) has reported positive top-line results from a phase 3 pivotal trial of esaxerenone (INN; code name CS-3150), a product of the companies’ prior research collaboration, in patients with essential hypertension in Japan. With the trial achieving its primary…
Page 1 of 73

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: